Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
about
Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health TreatmentNeuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophreniaMultilevel analysis of air pollution and early childhood neurobehavioral developmentRemoving obstacles in neuroscience drug discovery: the future path for animal models.Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.Animal models of schizophrenia.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.CNTRICS final animal model task selection: control of attentionAntioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine TreatmentRole of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in ratsEffect of second-generation antipsychotics on cognition: current issues and future challenges.Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaNew translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and ratsConvergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time taskRepeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of ratsSchizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviorsThe hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaComparative effects of different test day challenges on performance in the 5-choice serial reaction time task.Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.Prolonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex.Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulusStress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor.Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance taskOlanzapine Prevents the PCP-induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via NRG1Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.Effects of altering reinforcer magnitude and reinforcement schedule on phencyclidine (PCP) self-administration in monkeys using an adjusting delay task.Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.Asenapine effects in animal models of psychosis and cognitive function.Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in ratsIntact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method.Leading compounds for the validation of animal models of psychopathology.Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task.Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocolInhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task
P2860
Q26741515-3E216406-2BC3-4F78-A5AA-1005F45752B1Q27026382-24987A7D-3F9C-4160-9A92-0A87222F60CAQ28655196-DB266617-B7C5-4DB1-8CC7-A14C4AA674FFQ28755229-FC891B1B-7AB7-4717-B03D-FBE09FD11C99Q30403790-FF0A50E5-D808-4756-9012-886FE3AD0891Q30462828-88D905AC-F6A5-4BF8-83B6-8A1325780918Q30473707-39218915-142D-4524-B7C6-7AA8114098DCQ30489404-9B0B822C-7679-4B31-BF4A-BBDE33DFCCA2Q30527964-D776E6DA-1530-48F7-A879-105C073B1256Q33766147-BF5A461E-382D-41A9-81C0-1B2D586AAD99Q33848200-ED5E21D8-0A55-4967-AE29-7CE09A6B11B3Q33888153-CFC15C76-BD24-4733-A7E2-BB4BD2BE7822Q33936354-1009C238-10A8-4A06-AD9E-3517B73A9914Q33976994-AA120B22-BCB4-4A22-AED9-252BBF5E078BQ34181201-B2563C31-C509-4DED-9B49-E0C48AAF7160Q34407185-59E72D64-A9FF-4691-AD39-B8C48DF5AB7AQ34744336-EFD47D20-F900-42DB-8B62-F3FD4E00FABBQ35024121-FE7070FD-5C5B-4528-ACF5-6AF9EF311CE0Q35048154-55FA1DFB-CC1B-4B07-A3FC-D72D35D0A96DQ35132662-13761C00-6795-49B5-8BD9-CBE1149B9567Q35222750-D8C61CFE-A5CE-4C62-A155-9D56928D8B97Q35275505-18FE4D67-2429-4248-91EB-EA4359051B90Q35641833-A6CE40C7-0A9C-4489-8925-EFC13FA9C977Q35718134-C6885CCB-B6A6-4E31-8C18-888E9D4608A5Q35836459-E4A1E281-3378-43E2-AA6A-2D1B5C8B9974Q35957258-2B450D54-9A32-4870-9F43-82238555FC65Q36458968-B8E72777-1A7D-4746-9B8B-773B13EDCBE9Q36500134-D8D0667A-B7D6-410B-9E6F-C885C89FABBBQ36618769-97513612-8C7C-43DD-BAAB-7BE8A3D68A22Q36992070-1BD96244-6A30-46D0-84EA-DBEA07188C01Q37081349-A95CFA89-BB3E-44DE-A5FA-95C91756D816Q37212798-780FEC92-B1B6-45BB-96E7-4B9BA3305160Q37354597-02431A60-B7EF-420A-95F6-201A38F58F77Q37370296-E448AB11-3555-4C35-AC75-F364D5B37F92Q37417150-3BC4FD87-BEBD-40B9-93ED-21A5D71B44BDQ37506679-1FFC3F9F-4F29-4AF1-8310-0BCAB5A9155DQ38128733-D4A7A3B5-77B2-496A-8D6C-FE573D6FD9C8Q38223390-F0AD78E2-4E64-41CF-BC73-B1850DCBEFF7Q41494642-C5D75E6A-ED9D-47B9-9802-249FABCD60DEQ42409166-851FD051-63F5-48A3-B944-4E3DCE923A6A
P2860
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cognitive-disruptive effects o ...... psychotic medications in rats.
@en
Cognitive-disruptive effects o ...... psychotic medications in rats.
@nl
type
label
Cognitive-disruptive effects o ...... psychotic medications in rats.
@en
Cognitive-disruptive effects o ...... psychotic medications in rats.
@nl
prefLabel
Cognitive-disruptive effects o ...... psychotic medications in rats.
@en
Cognitive-disruptive effects o ...... psychotic medications in rats.
@nl
P2093
P2860
P1433
P1476
Cognitive-disruptive effects o ...... psychotic medications in rats.
@en
P2093
Athina Markou
Nurith Amitai
Svetlana Semenova
P2860
P2888
P304
P356
10.1007/S00213-007-0808-X
P577
2007-05-12T00:00:00Z